Real-time enrollment status for this paroxysmal nocturnal hemoglobinuria (pnh) clinical trial
Current Status
Recruiting
Checked: July 19, 2026 at 9:42 AM UTC
| NCT Number | NCT04901936 |
| Recruiting Status | Recruiting |
| Condition | Paroxysmal Nocturnal Hemoglobinuria (PNH) |
| Phase | PHASE2 |
| Target Enrollment | 12 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Apellis Pharmaceuticals, Inc. |
| Last Updated on CT.gov | June 26, 2026 (3 weeks ago) |
As of July 19, 2026: Clinical trial NCT04901936 is currently recruiting participants. This phase2 study for paroxysmal nocturnal hemoglobinuria (pnh) is actively seeking new participants at 1 location across the United States. The study is sponsored by Apellis Pharmaceuticals, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04901936 is actively recruiting participants as of July 19, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04901936 was last updated 3 weeks ago (June 26, 2026). HelloStudys verifies this status automatically.